A widely used blood pressure medication has been recalled across the United States because the pills may be contaminated with metal, federal health officials have announced.

Breckenridge Pharmaceutical is voluntarily recalling one lot of its propranolol hydrochloride extended-release capsules, 60 milligrams, after discovering that the batch may contain metal contamination. The recall was announced by the company on 16 November and published by the Food and Drug Administration on 20 November. It covers a single lot, sold in 100-count bottles, that was distributed nationwide to wholesalers and pharmacies between 26 October and 4 November 2026.

The details of the affected batch are specific, and they are worth checking carefully, because this is a recall of one lot only, not of the drug as a whole. The product is propranolol hydrochloride extended-release capsules, USP, 60 milligrams. The lot number is PK25110035. The national drug code, the number printed on the label that identifies the exact product, is 51991-817-01. The expiration date on the affected bottles is May 2029. If your bottle does not match all of those details, it is not part of this recall.

The reason for the recall is serious. According to the company, using capsules from the affected lot could cause lacerations, or cuts, to the soft tissues of the mouth, esophagus, stomach or intestine. Metal fragments in a capsule that is swallowed whole can scratch or tear the lining of the digestive tract as it travels through the body, and in the worst case, that can cause bleeding, pain, or damage that needs medical treatment. As of the date of the recall announcement, Breckenridge said it was not aware of any injuries or adverse events linked to the affected lot. That is good news, but it is not a guarantee: the lot was only on pharmacy shelves for a short time, and not everyone who took a capsule from it would necessarily have reported a problem.

The contamination appears to have come from the manufacturing process rather than from anything the patient did. The affected lot was made using intermediate material that is suspected to be the source of metal contamination found in a separate lot, one that was never released to the market. In other words, the company found the problem in one batch before it was sold, traced it to a shared ingredient, and then discovered that the same ingredient had gone into a batch that had already been shipped. That is how a recall of a single lot can happen even when a manufacturer catches the problem early.

Propranolol is a beta-blocker, one of the oldest and most widely prescribed types of heart and blood pressure medicine. It has been in use for decades, and it is prescribed not only for high blood pressure but also for chest pain, irregular heartbeats, tremor, and the prevention of migraine headaches. Millions of people in the United States take it every day, which is why even a recall of a single lot draws attention. For most of those people, nothing changes: their medication comes from a different lot, made from different materials, and it is safe to keep taking. But for the people who did receive a bottle from lot PK25110035, the advice is clear and urgent.

If you have the affected medication, stop taking it immediately and contact your doctor or another healthcare provider for medical advice and instructions on getting a replacement. Do not simply stop taking a blood pressure medicine without talking to a doctor, because stopping a beta-blocker suddenly can itself be dangerous: it can cause a rebound rise in blood pressure and heart rate, and in people with heart disease, it can trigger chest pain or a heart attack. That is why the company’s advice is to stop the recalled capsules and speak to your doctor at once, so that a safe replacement can be arranged without a gap in treatment. Any unused capsules from the recalled lot should be returned to the pharmacy where they were obtained.

People with questions about the recall can contact Qualanex, the recall service provider appointed by Breckenridge, on 1-855-736-0807, Monday to Friday from 9 a.m. to 5 p.m. Eastern Time, or by email at recall@qualanex.com. Your pharmacist can also check the lot number on your bottle and tell you whether it is affected, which is the simplest step for anyone who is unsure.

The propranolol recall is the latest in a series of problems with blood pressure medicines in recent weeks. In late October, another New Jersey company, Advagen Pharma, recalled 3,684 bottles of 50-milligram metoprolol tartrate tablets, a different beta-blocker, because they may have contained foreign tablets or capsules. Days before that, a different medicine was recalled over problems with how it delivered its dose. Each of these recalls is separate, involving different drugs, different manufacturers and different problems, but together they are a reminder of how much the safety of everyday medicines depends on manufacturing quality, and how quickly a problem in a single factory can reach pharmacies across the country.

That is not a reason to lose faith in prescription medicines. The system that caught this problem worked as it was supposed to: a manufacturer found contamination in one batch, traced it to a shared material, identified the other batch that used it, and pulled it from the market before any injuries were reported. The FDA published the recall, the news spread, and patients were told exactly which lot to check for.

For now, the advice is simple. If you take propranolol extended-release capsules, check your bottle for lot PK25110035. If it matches, stop taking it, call your doctor, and return the bottle to your pharmacy. If it does not match, carry on as usual. And if you are not sure, ask your pharmacist. That is what they are there for. A minute spent checking a lot number is a small price for peace of mind.

Leave a Reply

Your email address will not be published. Required fields are marked *